Company Description

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States.

It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.

The company was founded in 1984 and is based in San Diego, California.

Aethlon Medical, Inc.

Country	United States
Founded	1984
Industry	Medical Devices
Sector	Healthcare
Employees	9
CEO	James Frakes

Contact Details

Address: 11555 Sorrento Valley Road, Suite 203 San Diego, California 92121 United States
Phone	619 941 0360
Website	aethlonmedical.com

Stock Details

Ticker Symbol	AEMD
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	USD
CIK Code	0000882291
CUSIP Number	00808Y703
ISIN Number	US00808Y7031
Employer ID	13-3632859
SIC Code	3841

Key Executives

Name	Position
James B. Frakes M.B.A.	Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary and Director
Dr. Steven P. LaRosa M.D.	Chief Medical Officer
Michele Bombardiere	Vice President and Controller

Latest SEC Filings

Date	Type	Title
Aug 21, 2026	PRE 14A	Other preliminary proxy statements
Aug 13, 2026	10-Q	Quarterly Report
Aug 13, 2026	8-K	Current Report
Aug 13, 2026	SCHEDULE 13G/A	Filing
Jul 31, 2026	8-K	Current Report
Jul 8, 2026	8-K	Current Report
Jul 7, 2026	424B3	Prospectus
Jul 6, 2026	EFFECT	Notice of Effectiveness
Jul 1, 2026	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Jul 1, 2026	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933

View All SEC Filings